TGF-beta1 and endothelial/tissue injury with high-dose intravenous iron therapy in renal failure: evidence or perception?
Goździkiewicz
Joanna
J
Borawski
Jacek
J
Naumnik
Beata
B
Rydzewska-Rosołowska
Alicja
A
Pawlak
Krystyna
K
Myśliwiec
Michał
M
D004730:Endothelium, Vascular / Q000187:drug effects* / Q000503:physiopathology; D006801:Humans; D007262:Infusions, Intravenous; D007501:Iron / Q000008:administration & dosage* / Q000009:adverse effects; D007676:Kidney Failure, Chronic / Q000150:complications / Q000188:drug therapy*; D016212:Transforming Growth Factor beta / Q000097:blood / Q000502:physiology*; D053773:Transforming Growth Factor beta1
C508960:TGFB1 protein, human; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1; D007501:Iron